159870-95-8

Usage

Uses

Used in Pharmaceutical Industry:
2-chlorooxazolo[5,4-b]pyridine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of drugs with diverse therapeutic profiles. Its incorporation into drug molecules can enhance their efficacy and selectivity, leading to improved treatment options for a range of medical conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 2-chlorooxazolo[5,4-b]pyridine is utilized as a building block for the preparation of agrochemicals, such as pesticides and herbicides. Its chemical properties allow for the creation of compounds with effective pest control and weed management capabilities, contributing to increased crop yields and agricultural productivity.
Used in Research and Development:
2-chlorooxazolo[5,4-b]pyridine is employed as a research compound for exploring its potential biological activities, including antimicrobial, antiviral, and anti-inflammatory properties. Its use in scientific studies aids in understanding its mechanism of action and helps in the discovery of new therapeutic agents with novel modes of action.

Upstream product

• 6332-56-5 2-hydroxy-3-nitropyridine 
• 33630-99-8 2-hydroxy-3-aminopyridine 
• 169205-99-6 2-Mercaptooxazolo<5,4-b>pyridine 

Relevant academic research and scientific papers

HMOX1 inducers

The present invention is related to compounds of structure (I) as heme oxygenase 1 (HMOX 1) inducers. The present invention is also related a method of controlling the activity or the amount, or both the activity and the amount, of heme-oxygenase 1 in a mammalian subject. The definitions of the variables are provided herein.

SUBSTITUTED 2-AZABICYCLO[3.1.1]HEPTANE AND 2-AZABICYCLO[3.2.1]OCTANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

There is provided a compound of formula (I), wherein L1 to L3, R1 to R4, X, A and B have meanings given in the description, and pharmaceutically acceptable salts, solvates and prodrugs thereof, which compounds are useful as antagonists of the orexin-1 and orexin-2 receptors or as selective antagonists of the orexin-1 receptor, and thus, in particular, in the treatment or prevention of inter alia substance dependence, addiction, anxiety disorders, panic disorders, binge eating, compulsive disorders, impulse control disorders, cognitive impairment and Alzheimer's disease.

Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives

This invention is concerned with compounds of the formula wherein A, B1, B2, R1, R2 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.